quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:13:56·37d
INSIDERFiling
Henry Schein Inc. logo

CEO, Henry Schein Products Popeck Thomas C covered exercise/tax liability with 587 shares, decreasing direct ownership by 0.67% to 87,537 units (SEC Form 4)

HSIC· Henry Schein Inc.
Health Care
Original source

Companies

  • HSIC
    Henry Schein Inc.
    Health Care

Recent analyst ratings

  • Apr 16UpdateBTIG Research-
  • Apr 15UpdateCitigroup$100.00
  • Feb 23UpdateRobert W. Baird$100.00
  • Dec 9UpdateBarclays$86.00
  • Aug 26UpdateEvercore ISI$83.00
  • Jul 25UpdateStifel$75.00

Related

  • PR3d
    Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ET
  • ANALYST7d
    BTIG Research initiated coverage on Henry Schein
  • ANALYST8d
    Citigroup initiated coverage on Henry Schein with a new price target
  • SEC16d
    SEC Form DEFA14A filed by Henry Schein Inc.
  • SEC16d
    SEC Form DEF 14A filed by Henry Schein Inc.
  • PR16d
    Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.
  • INSIDER34d
    SEC Form 4 filed by Popeck Thomas C
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022